NCT07268703
Expiratory Muscle Training in Parkinson's Disease With Forward Trunk Flexion
At risk: Primary completion moved at least 12 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Mar 2026 to Apr 2027 Show 5 more changesShow less
- Start date: Dec 2025 to Feb 2027
- Eligibility criteria expanded, about 10 words
- Study completion pushed from May 2026 to Jun 2027
- Secondary endpoints: details revised at 6 of 6 entries
- Publications: details revised at 9 of 9 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (6)
Show 1 moreShow less
Arms and interventions
Participants in this arm have Parkinson's disease and forward trunk flexion, defined as thoracic flexion ≥25° or lumbar flexion ≥15° while standing and walking, which completely disappears when lying down. They will follow the study schedule including all assessments and the 4-week EMST program. Outcomes will include voluntary peak cough flow, respiratory muscle strength, swallowing function (FEES), drooling, and posture assessment using standardized photographs.
Participants in this arm have Parkinson's disease without forward trunk flexion (no postural abnormalities). They will follow the same study schedule including all assessments and the 4-week EMST program as the experimental group.
Devices: Expiratory muscle strength training
Sites
1 site in 1 country
- General University HospitalPrague, Czechia